AHRQ Patient Safety Network ► Identifying high-risk medication: a systematic literature review.

AHRQ Patient Safety Network

Systematic review identifies seven high risk medication classes: methotrexate, warfarin, NSAIDs, digoxin, opioids, aspirin, and beta-blockers.Euro J Clin Pharmacol. 2014;70:637-645.

Identifying high-risk medication: a systematic literature review.

Saedder EA, Brock B, Nielsen LP, Bonnerup DK, Lisby M. Euro J Clin Pharmacol. 2014;70:637-645.

This systematic review identified seven medication classes associated with the most severe medication errors: methotrexate, warfarin, nonsteroidal anti-inflammatory drugs, digoxin, opioids, aspirin, and beta-blockers. The authors suggest that focusing on these medication classes will reduce morbidity and mortality due to adverse drug events, a departure from the commonly advocated universal medication safety recommendations.

PubMed citation 
Available at 

Related Resources

STUDY

Insufficient communication about medication use at the interface between hospital and primary care.

Glintborg B, Andersen SE, Dalhoff K. Qual Saf Health Care. 2007;16:34-39.

STUDY

Seven hundred and fifty-nine (759) chances to learn: a 3-year pilot project to analyse transfusion-related near-miss events in the Republic of Ireland.

Lundy D, Laspina S, Kaplan H, Rabin Fastman B, Lawlor E. Vox Sang. 2007;92:233-241.

STUDY

Critical incidents related to cardiac arrests reported to the Danish Patient Safety Database.

Andersen PO, Maaløe R, Andersen HB. Resuscitation. 2010;81:312-316.

STUDY

Assessment of adverse events in medical care: lack of consistency between experienced teams using the Global Trigger Tool.

Schildmeijer K, Nilsson L, Arestedt K, Perk J. BMJ Qual Saf. 2012;21:307-314.

View all related resources...